ICD-10-CM Billable Code

C44.1

Other and unspecified malignant neoplasm of skin of eyelid, including canthus

Clinical Classification Guidelines

Excludes Type 1

  • connective tissue of eyelid (C49.0)

Medical Intelligence & Overview

Malignant skin neoplasm of the eyelid, with an ICD-10 code of C44.1, refers to cancers that originate from the skin tissues of the eyelid and surrounding areas such as the canthus, which is the corner where the eyelids meet. These cancers are part of a broader category of skin cancers but are specifically characterized by their location on the eyelid region. Early diagnosis and appropriate management are essential to prevent the spread of the disease and preserve eye health and vision.

Causes & Symptoms

Clinical Causes: Prolonged exposure to ultraviolet (UV) radiation from the sun or tanning beds Fair or light skin complexion, which provides less natural protection against UV exposure Chronic skin injuries or wounds in the eyelid region History of skin cancers or other predisposing skin conditions Exposure to certain chemicals or radiation Genetic predisposition or family history of skin cancers

Key Symptoms: A new or changing growth or sore on the eyelid that doesn’t heal A growth feeling like a lump or thickening on the eyelid Persistent redness or inflammation of the eyelid Ulcerated or bleeding lesion Change in color or size of a pigmented spot on the eyelid Discoloration or scaling that persists or worsens over time

Diagnostic & Treatment

Diagnosis Path: Diagnosis typically involves a thorough examination of the eyelid and surrounding skin by a healthcare professional. This may include visual inspection, dermatoscopy, and biopsy procedures such as excisional or incisional biopsy to confirm the presence of malignant cells. Imaging studies like ultrasound, CT scans, or MRI may be employed if the cancer has spread locally or to nearby structures. Accurate staging is essential for planning treatment strategies and involves assessing tumor size, depth, and potential spread.

Treatment Protocols: Treatment options vary depending on the size, location, and extent of the tumor. Common approaches include: - Surgical excision: Removing the tumor with clear margins, often combined with reconstructive procedures to restore eyelid function - Mohs micrographic surgery: A precise surgical technique that minimizes tissue removal while ensuring complete cancer removal - Radiotherapy: May be used in cases where surgery is contraindicated or as an adjunct post-surgery - Topical chemotherapy or immunotherapy: In select cases, topical treatments such as 5-fluorouracil or immune modulating agents can be used - Follow-up care: Regular monitoring to detect any recurrence or new lesions early Multidisciplinary management involving dermatologists, ophthalmologists, and oncologists is often essential for optimal outcomes.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C44.1 a billable ICD-10 code?
Yes, C44.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C44.1?
Clinical documentation must specify the nature of Other and unspecified malignant neoplasm of skin of eyelid, including canthus and any associated comorbidities for accurate reporting.

Cite this Clinical Reference